6.
Su L, Liu C, Wu W, Cui Y, Wu M, Chen H
. Successful Therapy for Myocarditis Concomitant With Complete Heart Block After Pembrolizumab Treatment for Head and Neck Squamous Cell Carcinoma: A Case Report With Literature Review. Front Cardiovasc Med. 2022; 9:898756.
PMC: 9133913.
DOI: 10.3389/fcvm.2022.898756.
View
7.
Jeyakumar N, Etchegaray M, Henry J, Lelenwa L, Zhao B, Segura A
. The Terrible Triad of Checkpoint Inhibition: A Case Report of Myasthenia Gravis, Myocarditis, and Myositis Induced by Cemiplimab in a Patient with Metastatic Cutaneous Squamous Cell Carcinoma. Case Reports Immunol. 2020; 2020:5126717.
PMC: 7355354.
DOI: 10.1155/2020/5126717.
View
8.
Hu Y, Liu C, Jin S, Yi Z, Wang C, Pan X
. A case of subclinical immune checkpoint inhibitor-associated myocarditis in non-small cell lung cancer. BMC Pulm Med. 2023; 23(1):119.
PMC: 10103507.
DOI: 10.1186/s12890-023-02417-4.
View
9.
Dougan M, Luoma A, Dougan S, Wucherpfennig K
. Understanding and treating the inflammatory adverse events of cancer immunotherapy. Cell. 2021; 184(6):1575-1588.
PMC: 7979511.
DOI: 10.1016/j.cell.2021.02.011.
View
10.
Zhong P, Zhang C, Guan H, Yan J, He M, Zhou X
. Myocarditis and myasthenia gravis induced by immune checkpoint inhibitor in a patient with relapsed thymoma: A case report. Clin Case Rep. 2023; 11(3):e7039.
PMC: 10032037.
DOI: 10.1002/ccr3.7039.
View
11.
Arangalage D, Delyon J, Lermuzeaux M, Ekpe K, Ederhy S, Pages C
. Survival After Fulminant Myocarditis Induced by Immune-Checkpoint Inhibitors. Ann Intern Med. 2017; 167(9):683-684.
DOI: 10.7326/L17-0396.
View
12.
Ke G, Chen P, Luo J, Huang J, Shang Y, Huang Y
. Plasma exchange plus glucocorticoids in the treatment of immune checkpoint inhibitor-induced myocarditis: A case series and review. Clin Cardiol. 2023; 46(12):1481-1487.
PMC: 10716322.
DOI: 10.1002/clc.24149.
View
13.
Luo Y, Tang W, Zeng Q, Duan W, Li S, Yang X
. Case Report: The Neuromusclar Triad of Immune Checkpoint Inhibitors: A Case Report of Myositis, Myocarditis, and Myasthenia Gravis Overlap Following Toripalimab Treatment. Front Cardiovasc Med. 2021; 8:714460.
PMC: 8415306.
DOI: 10.3389/fcvm.2021.714460.
View
14.
Barry T, Gallen R, Freeman C, Agasthi P, Pedrotty D, Yang M
. Successful Treatment of Steroid-Refractory Checkpoint Inhibitor Myocarditis with Globulin Derived-Therapy: A Case Report and Literature Review. Am J Med Sci. 2021; 362(4):424-432.
DOI: 10.1016/j.amjms.2021.04.018.
View
15.
Kee W, Ng K, Lee J, Tan D
. Myasthenia Gravis and Myocarditis After Administration of Pembrolizumab in a Patient With Metastatic Non-small Cell Lung Cancer and Resected Thymoma. Clin Lung Cancer. 2022; 23(4):e293-e295.
DOI: 10.1016/j.cllc.2021.12.001.
View
16.
Guo C, Alexander M, Dib Y, Lau P, Weppler A, Au-Yeung G
. A closer look at immune-mediated myocarditis in the era of combined checkpoint blockade and targeted therapies. Eur J Cancer. 2019; 124:15-24.
DOI: 10.1016/j.ejca.2019.09.009.
View
17.
Onderko L, Heinrich R, Gosling K, Downs T, Afari M
. Myocarditis Following Immune Checkpoint Inhibition With Pembrolizumab: Management in a Context of Steroid Intolerance. CJC Open. 2022; 4(10):854-857.
PMC: 9568688.
DOI: 10.1016/j.cjco.2022.07.002.
View
18.
Faak F, Buni M, Falohun A, Lu H, Song J, Johnson D
. Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events. J Immunother Cancer. 2023; 11(6).
PMC: 10277540.
DOI: 10.1136/jitc-2023-006814.
View
19.
Levin A, Wildenberg M, van den Brink G
. Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease. J Crohns Colitis. 2016; 10(8):989-97.
DOI: 10.1093/ecco-jcc/jjw053.
View
20.
Fazel M, Jedlowski P
. Severe Myositis, Myocarditis, and Myasthenia Gravis with Elevated Anti-Striated Muscle Antibody following Single Dose of Ipilimumab-Nivolumab Therapy in a Patient with Metastatic Melanoma. Case Reports Immunol. 2019; 2019:2539493.
PMC: 6515062.
DOI: 10.1155/2019/2539493.
View